Özündeki Faydalar V-160 'da Saklı

 

Aşağıda verilen sağlık bilgileri Dr. Morton WALKER 'ın  "OLIVE LEAF EXTRACT" kitabından alıntılardır. 

Zeytin Yaprağı Ekstraktının Anti Mikrobiyal Ajan Olarak Etkili Olduğu Bulaşıcı Hastalıkların Listesi

• AIDS
• Amoebiasis (Amipli Dizanteri)
• Anthrax (Şarbon)
• Athlete’s Foot ( Ayak Mantarı)
• Bladder Infection (İdrar Yolu Enfeksiyonu)
• Botulism (Gıda Zehirlenmesi)
• California Encephalitis (Kaliforniya Ensefaliti)
• Campylobacter (Kompilobakter)
• Cat-Scratch Disease ( Kedi Tırmığı Hastalığı)
• Chancroid (Şankroid)
• Chicken Pox ( Suçiçeği)
• Klamidya (Chlamydia)
• Klamidyal Pnömoni (Chlamydial Pneumonia)
• Kolera
• Clostridium Perfringens Enfeksiyonu
• Soğuk Algınlığı
• Uçuk (Herpes Simplex I)
• Konjonktivit (Göz Nezlesi, Pink Eye)
• Kasık Biti (Pediculosis Pubis)
• Kuş Palazı Hastalığı
• Kriptosporidyoz
• Sitomegalovirüs (CMV)
• İshal Hastalıkları
• Difteri
• Kulak Enfeksiyonları (Otitis Media)
• Doğu At Ensefaliti (Eastern Equine Encephalitis, EEE)
• Ebola Sudan Virüs Enfeksiyonu
• Ebola Zaire Virüs Enfeksiyonu
• Koli Basili 0157:H7 (Eschericha coli Hemorrhagic Colitis 0157:H7)
• Ensefalit
• Epstein-Barr Virüs (EBV) Enfeksiyonu
• Beşinci Hastalık (Parvovirüs B19'un yol açtığı çocuk hastalığı; Erythema Infectiosum)
• Flu (İnfluenza)
• Gıda Kaynaklı Hastalıklar (Gıda Zehirlenmeleri)
• Mide Ülserleri (Helikobakter Pilori)
• Gastroenterit (Mide ve Bağırsak İltihabı)
• Genital Uçuk (Herpes Simplex II)
• Genital Siğiller (HPV, İnsan Papillom Virüsü)
• Kızamıkçık (Rubella)
• Giyardiya (Giardiasis)
• Bel Soğukluğu (Gonorrhea)
• Grup B Streptokok (GBS) Hastalığı
• El, Ayak ve Ağız Hastalığı
• Hantavirus Pulmoner Sendromu (HPS)
• Saç Biti
• Hepatit
• Hepatit A
• Hepatit B
• Hepatit C
• Herpes Zoster (Şinglez)
• Haemophilus Enflüenza Enfeksiyonu veya Hib (Haemophilus Enflüenza Menejiti)
• İmpetigo
• Yenidoğan Botulizmi
• Japon Ensefaliti  (Japanese Encephalitis JE)
• Kasık Mantarı (Tinea Cruris)
• Lejyoner Hastalığı
• Cüzzam (Hansen Hastalığı)
• Leptospiroz (Sıtma)
• Listeriya (Listeriosis)
• Kazıklıhumma (Tetanoz)
• Lyme Hastalığı
• Akut Lösemi / Lenfoma Virüsüne Bağlı Lenfositik Lösemi
• Sıtma
• Marburg (Maymun) Virüsü [Rhabdovirus simiae]
• Kızamık (Rubeola)
• Bakteriyel Menenjit
• Viral Menenjit
• Meningokoksik Menenjit
• Beze Humması (Mono, Enfeksiyöz Mononükleozis)
• Kabakulak
• Mikoplasma Pnömonisi
• Newcastle Hastalığı
• Norwalk Virüsü (Norovirüs)
• Papağan Hastalığı (Psittakoz)
• Pastörella (Pasteurellosis)
• PID (Pelvik Enflamasyon Hastalığı)
• Pink Eye (Konjonktivit, Göz Nezlesi)
• Kılkurdu (Pinworm)
• Veba
• Pnömokoksal Menenjit
• Bronşal, Lobal, Segmental Pnömoni
• Bakteriyel Pnömoni
• Klamidyal Pnömoni
• Mikoplasma Pnömonisi
• Viral Pnömoni
• Çocuk Felci (Poliomyelitis)
• Domuz Tenyası
• Balkan Gribi (Query Fever)
• Kuduz
• Sıçan Humması Ateşi
• Ateşli Römatizma
• Saçkıran Mantar Enfeksiyonu (Tinea Capitis), (Tinea Corporis)
• Kayalık Dağlar Benekli Humması
• İsilik (Exanthem Subitem)
• Retrovirüs Enfeksiyonları
• Rotavirüs İshali
• Yuvarlak Solucan (Toxocariasis)
• RSV (Respiratuvar Sinsitiyal Virüs)
• St. Louis Ensefaliti  (St. Louis Encephalitis, SLE)
• Salmonella (Salmonellosis)
• Uyuz
• Kızıl Hastalığı (Scarlatina)
• Cinsel Yolla Bulaşan Hastalıklar
• Şigella (Shigellosis)
• Şinglez (Herpes Zoster)
• Çiçek Hastalığı (Variola)
• Stafilokokkal Gıda Zehirlenmesi
• Strepkokokal Boğaz Ağrısı
• Sifilis
• Tüberküloz (TB)
• Pamukçuk (Oral Kandida)
• Toksik Şok Sendromu (TSS)
• Toksoplazmoz
• Triş (Trichmoniasis)
• Trişinoz (Trichinellosis, Bağırsak Kurdu Hastalığı)
• TB (Tüberküloz)
• Karahumma (Tifo Ateşi)
• İdrar Yolları Enfeksiyonu
• Vajinal Maya Enfeksiyonu (Vajinal Kandida Mantarı)
• Vajinit (Vaginosis, Dölyolu Yangısı)
• Vinsan Anjini
• Siğil
• Boğmaca (Pertussis)
• Maya Sendromu (Polisistemik Kronik Kandida)
• Sarıhumma
• Yersinia (Yersiniosis)

Virüs, Bakteri ve Mantar gibi Patalojik Organizmalara Karşı Uygulanan Zeytin Yaprağı Ekstraktı Tedavisinin Sonuçları

 

Hastalıklar	Hasta Sayısı	Tam İyileşen	İyileşen	Stabil Kalan	Kötüleşen
Solunum yolu hastalıkları (bademcik iltihabı, farenjit, soluk borusu iltihabı, vb.)	119	115	4	-	-
Akciğer hastalıkları (pnömoni, bronşit, vb.)	45	42	3	-	-
Diş hastalıkları (pulpit, lökoplazi, ağız iltihabı, vb.)	67	60	5	2	-
Cilt hastalıkları (herpes ve diğer viral cilt problemleri)	172	120	52	-	-
Bakteriyel cilt enfeksiyonları (piyoderma, yaralanmalar)	37	30	7	-	-
Ülser hastalıkları (Helikobakter pilori enfeksiyonuna bağlı olanlar)	17	-	17	-	-
Bağışıklığın kuvvetlenmesi	43	Uygulanmaz	40	3	-

 

 

Yukarıdaki tabloya göre kliniğin çıkarımları şöyledir:

1. Tüm bakteriyel ve viral enfeksiyonlarda iyileşme ve gelişme yaklaşık yüzde 98 oranında sağlanmıştır.

2. Bu klinik çalışmada yer alan tüm hastaların bağışıklık direnci kuvvetlenmiştir.

3. Çocuklar ve ergenler de dahil, test edilen hastalar arasında olumsuz yan etki gözlemlenmemiştir.

 

Araştırma kapsamında yer alan hastaların özellikleri:

Cinsiyet : %58 kadın        %48 erkek

Yaş: 10 – 20 yaş arası:    12                       

30 – 40 yaş arası: 143

20 – 30 yaş arası:            117                     

40 – 50 yaş arası: 181

                                                                       

50 ve üzeri yaş:    47      

                                                                       

Hasta sayısı:          500

Kaynak: Budapeşte, Macaristan 'daki The Robert Lyons Clinic tarafından gerçekleştirilen Klinik Çalışma Araştırmayı yürüten: Robert Lyons, O.M.D., M.S.

 

 

BÖLÜM 1: MİKROP DENİZİNDE YÜZÜYORUZ

BÖLÜM 1 KAYNAKÇA:
1. Stoffman, P. The Family Guide to Preventing and Treating 100 Infectious lllnesses (New York: John Wiley& Sons, Inc., 1995), p. 1.
2. Shulman, S. T. "Introduction to infectious diseases." In The Biologic and Clinical Basis of Infectious Diseases, 5th edition. Editors S. T. Shulman, J.P. Phair, L. R. Peterson, and J. R.Warren (Philadelphia: W. B. Saunders Company, 1997), p. 1.
3. Herceg, R. J., and Peterson, L. R. "Normal flora in health and disease." In The Biologic and Clinical Basis of Infectious Diseases, 5th edition. Editors S. T. Shulman, J.P. Phair, L. R. Peterson, and J. R. Warren (Philadelphia: W. B. Saunders Company, 1997), p. 13.
4. Diseases, 2nd edition (Springhouse, PA: Springhouse Corporation, 1997), p. 95.
5. Professional Guide to Diseases, 5th edition (Springhouse, PA: Springhouse Corporation,1995), p. 145.
6. Ibid., p. 144.
7. Diseases, op. cit., p. 95. 
8. Trowbridge, J.P., and Walker, M. The Yeast Syndrome (New York: Bantam Books, 1986),p. 39.
9. Emond, R. T. D.; Rowland, H. A. K.; Welsby, P. D. Color Atlas of Infectious Diseases, 3rd edition (London: Times Mirror International Publishers, Ltd., 1995), p. 7.
10. Brant, M.; Wingert, P.; Hager, M. "The end of antibiotics." Newsweek, March 28, 1994, pp. 47-51.
11. Stoffman, op. cit., p. 8.
12. Gittleman, A. L. Guess What Came to Dinner: Parasites and Your Health (Garden City Park, NY: Avery Publishing Group, Inc., 1993), p. 21.
13. Dubos, R. J. "The evolution and the ecology of microbial diseases. In Bacterial and Mycotic Infections of Man ( 3rd edition), editor Rene J. Dubos, (Philadelphia: J.B. Lippincott Co., J 958), pp. 14-27.

BÖLÜM 2: ZEYTİN YAPRAĞI EKSTRAKTININ ANTİ MİKROBİYAL İLAÇ OLARAK GELİŞİMİ

BÖLÜM 2 KAYNAKÇA:
1. Tranter, H. S.; Tassou, S. C.; Nychas, G. J. "The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. Journal of Applied Bacteriology 74:253-259, 1993.
2. Pasquale, A. D.; Monforte, M. T.; Calabro, M. L. "HPLC analysis of oleuropein and some flavonoids in leaf and bud of Olea Europaea L. II Farmaco 46(6):803-815, 1991.
3. Rosenblum, M. Olives: The Life and Lore of a Noble Fruit (New York: Farrar, Straus & Giroux, 1996), p. 55.
4. Renis, H. E. "In vitro antiviral activity of calcium elenolate.'' Antimicrobial Agents and Chemotherapy pp. 167-168, 1970.
5. Elliot, G. A.; Buthala, D. A.; De Young, E. N. "Preliminary safety studies with calcium elenolate, an antiviral agent." Antimicrobial Agents and Chemotherapy 173-176, 1969.
6. Trowbridge, J. P., and Walker, M. The Yeast Syndrome (New York: Bantam Books, I 986), pp. 132-133.
7. Baker, S. M. Notes on the Yeast Problem (New Haven: Gessell Institute of Human Development, 1985), p. 8.
8. Privitera, J. R. Olive Leaf Extract: A New/Old Healing Bonanza for Mankind (Covina, CA: NutriScreen, Inc., 1996).
9. Barilla, J. Olive Oil Miracle: How the Mediterranean Marvel Helps Protect Against Arthritis, Heart Disease and Breast Cancer (New Canaan, CT: Keats Publishing, Inc., 1996), pp. 43-44.
10. Ibid., pp. 36-38.
11. Simopoulos, A. P. "The Mediterranean food guide. Greek column rather than an Egyptian pyramid." Nutrition Today 30(2):54-6 I, 1995.

BÖLÜM 3: ZEYTİN YAPRAĞI EKSTRAKTININ ŞİFALI BİLEŞENLERİNİN ORTAYA ÇIKARILMASI 

BÖLÜM 3 KAYNAKÇA:
1. Pallas, E. Recueil de Memoires de Medecine, de Chirurgie, et de Pharmacie Militaires, vol.xxiii (1827), p. 152.
2. Pallas, E. Journal Universe/ des Sciences Medicales, tome XIX, 1828, p. 257.
3. Pallas, E. Recueil de Memoires de Medecine, de Chirurgie, et de Pharmacie Militaires, vol.xxvi ( 1829), p. 159.
4. Petkov, V., and Manolov, P. "Pharmacological analysis of the iridoid oleuropein."Arzneim.-Forsch. (Drug Research) 22(9):1476-1486, Nov. 9, 1972.
5. Fleming, H. P.; Walter, W. M.; Etchells, J. L. "Antimicrobial properties of oleuropein and products of its hydrolysis from green olives." Microbiology 26(5):777-782, Nov. 1973.
6. Tassou, C. C.; Nychas, G. J.E.; Board, R. G. "Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores. Biotechnology Applied Biochemistry 13:231-237, 1991.
7. Elliott, G. A.; Buthala, D. A.; De Young, E. N. "Preliminary safety studies with calcium elenolate, an antiviral agent." Antimicrobial Agents and Chemotherapy, 1970, pp. 173-176.
8. Ibid., p. 176.
9. Tranter, H. S.; Tassou, S. C.; Nychas, G. J. "The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. '' Journal of Applied Bacteriology 74:253-259, 1993.
10. Vaugh, R.H., in Industrial Fermentations, Editors L.A. Underkofler and R. J. Hickey, Vol. 2 (New York: Chemical Publishing, 1954 ).
11. Noskin, G. A. "Nosocomial infections." In The Biologic and Clinical Basis of Infectious Diseases, 5th edition. Editors S. T. Shulman, J.P. Phair, L. R. Peterson, and J. R. Warren. (Philadelphia: W. B. Saunders Company, 1997), pp. 382-395.
12. Ibid., pp. 386-388.
13. Bourquelot, E., and Vintilesco, J. "Sur l'oleuropeinnouveau principle de nature glucosidique retire de l'olivier (Olea europea L)." Comptes Rendus Hebdomadaires des Seances de L'Academie des Sciences. Paris, 147:533, 1908.
14. Juven, B.; Henis, Y.; Jacoby, B. "Studies on the mechanism of the antimicrobial action of oleuropein." Journal of Applied Bacteriology 35:559-567, 1972.
15. Harborne, J.B. "Phenolic glucosides and the natural distribution.'' In Biochemistry of Phenolic Compounds, editor J. B. Harborne, (London: Academic Press, 1964).
16. Fleming, Walter, Etchells, op. cit.
17. Gourama, H., and Bullerman, L. B. "Effects of oleuropein on growth and aflatoxin production by Aspergillus parasiticus." Dept. Food Science & Technology, University of Nebraska, Lincoln, NE 68583-0919, 1987.
18. Tassou, C. C., and Nychas, G. J. E. "Inhibition of Staphylococcus aureus by olive phenolics in broth and in a model food system." Journal of Food Protection 57( 2):120-124, Feb. 1994.
19. Tranter, H. S.; Tassou, S. C.; Nychas, G. J. "The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. '' Journal of Applied Bacteriology 74:253-259, 1993.
20. Nychas, G. J. E.; Tassou, S. C.; Board, R. G. Letters in Applied Microbiology 10:217-220,1990.
21. Federici, F., and Bongi, G. ''Improved method for isolation of bacterial inhibitors from oleuropein hydrolysis." Applied and Environmental Microbiology. 46(3):509-510, 1983.
22. Fleming, Walter, Etchells, op. cit. Halstead, B. W. The Scientific Basis of EDTA Chelation Therapy. (Colton, CA: Golden Quill Publishers, Inc., 1979), p. 75. Hanbury, D. " On the febrifuge properties of the olive (Olea europaea, L)" Journal Universe/ des Sciences Medicales, tome xix, p. 257. Konlee, M. "The olive leaf." Positive Health News, No. 11, Spring 1996 (Keep Hope Alive, P.O. Box 27041, West Allis, WI 53227). Pasquale, A. D.; Monforte, M. T.; Calabro, M. L. "HPLC analysis of oleuropein and some flavonoids in leaf and bud of Olea europaea L. II Pharmaco 46(6):803-816, 1991. Petkov and Manolov, op. cit. Renis, H. E. " In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy, pp. 167-168, 1970. Tassou, C. C.; Nychas, G. J. E.; Board, R. G. "Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores. Biotechnology Applied Biochemistry 13:231-237, 1991. Tranter, Tassou, Nychas, op. cit. Tutour, B. L., and Guedon, D. " Antioxidative activities of Olea europaea leaves and related phenolic compounds.'' Phytochemistry 31(4):11 73-1178, 1992. Vaugh, R.H., in Industrial Fermentations, editors L. A. Underkofler and R. J. Hickey, Vol. 2 (New York: Chemical Publishing, 1954 ).
23. Dring, G. J., and Gould, G. W. Journal of General Microbiology 65:101-104, 1971 Elliott, G. A.; Buthala, D. A.; De Young, E. N. "Preliminary safety studies with calcium elenolate, an antiviral agent." Antimicrobial Agents and Chemotherapy, 8: 173-199, 1975. Fleming, H.P., and Etchells, J. L. Applied Microbiology 15:1178-1184, 1967. Fleming, H.P.; Walter, W. M.; Etchells, J. L. Applied Microbiology 18:856-860, 1969. Gould, G. W.; Hitchins, A. D.; King, W. L. Journal of General  icrobiology 44:293-302, 1966. Heinze, J.E.; Hale, A.H.; Carl, P. L. "Specificity of the anti-viral agent calcium elenolate." Antimicrobial Agents and Chemotherapy 8(4):421-425. Juven, R. & Henis, Y. Journal of Applied Bacteriology 33:721-732, 1970. Moreno, E.; Perez, J.; Ramos-Cormezana, A.; Martinez, J. Microbios 51:169-174, 1974. Nychas, Tassou, Board, op. cit. Paredes, M. J.; Moreno, E.; Ramos-Cormenzana, A.; Martinez, J. Chemosphere 16:1557-1564, 1987. Paredes, M. J.; Monteolina-Sanchez, M.; Moreno, E.; Perez, J.; Ramos-Cormenzana, A.; Martinez, J. Chemosphere 15:659-664, 1986. Paster, N.; Juven, B. J.; Harshemesh, H. Journal of Applied Bacteriology 64:293-297, 1988. Renis, H. E. "In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy, pp. 167-172, 1969. Rodriguez, M. M.; Perez, J.; Romps-Cormenzana, A.; Martinez, J. Journal of Applied Bacteriology 64:219-225, 1988. Ruiz-Barba, J. L.; Rios-Sanchez, R. M.; Fedriani-Iriso, C.; Olias, J.M.; Rios, J. L.; Jimenez-Diaz, R. Syst. Appl. Microbial. 13:199-205, 1990. Soret, M. G. '' Antiviral activity of calcium elenolate on parainfluenza infection of hamsters." Antimicrobial Agents and Chemotherapy, pp. 160-166, 1969. Vazqeuz-Roncero, A.; Maestro Duran, M.; Graciani, Constante, E. Grasas Aceites (Seville) 25:341-345, 1974.

BÖLÜM 4: ZEYTİN YAPRAĞININ ANTİ MİKROBİK ÖZELLİKLERİ VE ETKİLİ OLDUĞU BULAŞICI HASTALIKLAR

BÖLÜM 4 KAYNAKÇA:
1. Rosenblum, M. Olives: The Life and Lore of a Noble Fruit (New York: Farrar, Straus & Giroux, 1996), pp. 195-196.
2. Ibid., p. 196.
3. Asaka, Y.; Kamikawa, Tk.; Kubota, T.; Sakamoto, H. "Structures of seco-iridoids from Ligstrum oblusifolium." Chemical Letters 00: 141-144, 1972.
4. Kubo, I.; Matsumoto, A.; Takase, I. "A multichemical defense mechanism of bitter olive Olea europaea (Oleaceae): ls oleuropein a phytoalexin precursor?" Journal of Chemical Ecology 11(2):251-263, 1985.
5. De Whalley, C. V.; Rankin, S. M.; Hoult, J. R. S.; Jessup, W.; Leake, D. S. Biochem Pharmacology 39:1743-1750, 1990. Elliot, G. A.; Buthala, D. A.; De Young, E. N. "Preliminary safety studies with calcium elenolate, an antiviral agent." Antimicrobial Agents and Chemotherapy 173-176, 1969. Fleming, H.P., and Etchells, J. L. "Occurrence of inhibitor of lactic acid bacteria in green olives." Applied Microbiology 14:1178-1184, 1967. Fleming, H.P.; Walter, W. M.; Etchells, J. L. Applied Microbiology 18:859-860, 1969. Hertog, M. G. L.; Feskens, E. J.M.; Hollman, P. C. H.; Katan, M. B.; Kromhout, D. Lancet 342: 1007-1011, 1993. lnven, B., and Henis, Y. Journal of Applied Bacteriology 33:721-732, 1970. Kunhau, J. World Revue of Nutrition and Diet 24:117-191, 1976. Moreno, E.; Perez, J.; Ramos-Cormezana, A.; Martinez, J. Microbios 51:169-174, 1987. Mortimer, P.R., and McCann, G. "Food poisoning episodes associated with Bacillus cereus in fried rice." Lancet 1: 1043-1045, 1974. Nychas, G. J.E.; Tassou, S. C.; Board, R. G. Letters in Applied Microbiology 10:217-220, 1990.Paredes, M. J.; Monteleolina-Sanchez, M.; Moreno, E.; Perez, J.; Ramos-Cormenzana, A.;Martinez, J. Chemosphere 15:659-664, 1986. Paredes, M. J.; Moreno, E.; Ramos-Cormenzana, A.; Martinez, J. Chemosphere 16:1557-1564, 1987.Parker, M. S., and Bradley, M. J. Canadian Journal of Microbiology 141 :745-746, 1968.Pasquale, A. D.; Monforte, M. T.; Calabro, M. L. "HPLC analysis of oleuropein and some flavonoids in leaf and bud of Olea europaea L." II Farmaco 46(6):803-815, 1991. Paster, N.; Juven, B. J.; Harshemesh, H. Journal of Applied Bacteriology 64:293-297, 1988. Renis, H. E. " In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy pp. 167-168, 1970. Rodriguez, M. M.; Perez, J.; Romps-Cormenzana, A.; Martinez, J. Journal of Applied Bacteriology 64:219-225, 1988. Rutz-Barba, J. L.; Rios-Sanchez, R. M.; Fedriant-Iriso, C.; Olias, J.M.; Rios, J. L.; Ji-Menez, Diaz, R. System Applied Microbiology 13:199-205, 1990. Sierra, G. Canadian Journal of Microbiol 16:51-52, 1970. Tassou, C. C.; Nychas, G. J.E.; Board, R. G. "Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores.'' Biotechnology Applied Biochemistry 13:231-237, 1991. Tranter, H. S.; Tassou, S. C.; Nychas, G. J. "The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus. Journal Applied Bacteriology 74:253-259, 1993. Vaughn, R.H., in Industrial Fermentations, Editors L.A. Underkotler, and R. J. Hickey, Vol.2 (New York: Chemical Publishing, 1954).
Vazquez-Roncero, A.; Maestro Duran, M.; Graciani, C. E. Grrasas Aceites 25:341-345, 1974. Visioli, F., and Galli, C. "Oleuropein protects low density lipoprotein from oxidation." Life Sciences 55(24): 1965-1971, 1994. Visioli, F.; Vinceri, F. F.; Galli, C. "Waste waters' from olive oil production are rich in natural antioxidants (Basel: Virkhauser Verlag, 1995), p. 32-34.

BÖLÜM 5: ZEYTİN YAPRAĞI KONSANTRESİNİN DİĞER ŞİFALI UYGULAMA ALANLARI

BÖLÜM 5 KAYNAKÇA:
1. Petkov, V., and Manolov, P. "Pharmacological studies on substances of plant origin with coronary dilatating and antiarrhythmic action.'' Comparative Medicine East and West Vl(2): 123-130, 1978.
2. Ibid., p. 130.
3. Zarzuelo, A.; Duarte, J.; Jimenez, J.; Gonzales, M.; Utrilla, M. P. "Vasodilator effect of olive leaf." Planta Medicine 57:417-419, 1991.
4. Petkov, V., and Manolov, P. "Pharmacological analysis of the iridoid oleuropein." Arzneim.-Forsch. (Drug Research) 22:1476-141486, Nov. 9, 1972.
5. Ibid., pp. 1478-1479.
6. Petkov, V. "Plants with hypotensive, antiatheromatous and coronarodilatating action." American Journal of Chinese Medicine Vll(3):197-236, 1979.
7. Samuelsonn, G. "The blood pressure lowering factor in leaves of Olea europaea." Farmacevitisk Revy 15:229-239, 1951.
8. Panizzi, L., et al. "The constitution of oleuropein, a bitter glucoside of the olive with hypotensive action." Gass. Chim. Ital. 90:1449-1485, 1960.
9. The Merck Manual, 16th edition (Rahway, NJ: Merck & Co., 1992), p. 475.
10. Walker, M. "Antimicrobial attributes of olive leaf extract." Townsend Letter for Doctors & Patients, #156, July 1996, pp. 80-85.
11. Walker, M. "Olive leaf extract: The new oral treatment to counteract most types of pathological organisms." Explore! for the Professional 7(4):31-37, Nov. 1996.
12. Visioli, F., and Galli, C. "Oleuropein protects low density lipoprotein from oxidation." Life Sciences 55(24): 1865-1971, 1994.
13. Ruiz-Gutierrez, V.; Muriana, F. J. G.; Maestro, R.; Graciani, E. "Oleuropein on lipid and fatty acid composition of rat heart." Nutrition Research 15(1):37-51, 1995.
14. Kunhau, J. World Revue of Nutrition and Diet 24:117-191, 1976.
15. De Whalley, C. V.; Rankin, S. M.; Hoult, J. R. S.; Jessup, W.; Leake, D.S. Biochemistry and Pharmacology 39:1743-1750, 1990.
16. Hertog, M. G. L.; Feskens, E. J.M.; Hollman, P. C.H.; Katan, M. B.; Kromhout, D. Lancet 342:1007-1011, 1993.
17. Visioli, F.; Vinceri, F. F.; Galli, C. "Waste waters" from olive oil production are rich in natural antioxidants (Basel: Virkhauser Verlag, 1995), pp. 32-34.
18. Tutour, B. L., and Guedon, D. "Antoxidative activities of Olea europaea leaves and related phenolic compounds." Phytochemistry 31 (4): 1173-1178, 1992.
19. Privitera, J. R. Olive Leaf Extract-A New/Old Healing Bonanza for Mankind (Covina, California: James R. Privitera, 1996), p. 33.

BÖLÜM 6: SEVDİKLERİNİZİ HERPES VE DİĞER VİRAL HASTALIKLARDAN KORUYABİLİRSİNİZ

BÖLÜM 6 KAYNAKÇA:
1. The Merck Manual, 16th edition (Rahway, NJ: Merck & Co., Inc., 1992), pp. 270-271.
2. Weiner, M. A. Maximum Immunity (Bath, England: Gateway Books, 1986), pp. 145-149.
3. Emond, R. T. D.; Rowland, H. A. K.; Welsby, P. D. Color Atlas of Infectious Diseases, 3rd edition (London: Mosby-Wolfe, 1995), p. 204.
4. Professional Guide to Diseases, 5th edition (Springhouse, PA: Springhouse Corporation, 1995), p. 216.
5. Kennedy, R. P. Herpes: How to Live with It; How to Treat It; How Not to Treat It. (Santa Barbara, CA: American Medical Publishing Co., 1983), pp. 6-12.
6. Konlee, M. How to Reverse Immune Dysfunction, 5th edition. (West Allis, WI: Keep Hope Alive, 1996), p. 11.
7. Tedder, R.; Briggs, M.; Cameron, C. H.; Honess, R.; Robertson, D.; Whittle, H. "A novel lymphotropic herpesvirus." Lancet/2:390-392, 1987.
8. Fox, J. D.; Briggs, M.; Ward, P. A., et al. "Human herpesvirus 6 in salivary glands." Lancet 336:590-594, 1990. Harnett, G. E.; Farr, T. J.; Pietroboni, G. R., et al. "Frequent shedding of HHV-6 in saliva. J. Med. Virol. 30:128-130, 1990.
9. Levine, Arnold J. Viruses (New York: Scientific American Library, 1992), pp. 84-85.
10. Tanaka, K.; Kondo, T.; Torigoe, S.; Okada, S.; Mukai, T.; Yamanishi, K. "Human herpesvirus 7: Another casual agent for roseola (exanthem subitum)." Journal of Pediatrics 125(1 ): 1-5, July 1994.
11. Renis, H. E. "In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy, 1970, pp. 167-171.
12. Kaij-a-Kamb, M.; Amoros, M.; Girre, L. "Search for new antiviral agents of plant origin."Pharma-Acta-Helv, 67(5-6):130-147, 1992.

BÖLÜM 7: KRONİK YORGUNLUK SENDROMUNUN VİRAL NEDENLERİNİN ORTADAN KALDIRILMASI 

BÖLÜM 7 KAYNAKÇA:
1. Holms, Gary, P.; Kaplan, Jonathan E.; Gantz, Nelson M.; Komaroff, Anthony L.; Schonberger, Lawrence B.; Straus, Stephen E.; Jones, James F.; Dubois, Richard E.; Cunningham-Rundles, Charlotte; Pahwa, Savita; Tosato, Giovanna; Zegans, Leonard S.; Purtilo, David T.; Brown, Nathaniel; Schooley, Robert T.; and Brus, Irena. "Chronic fatigue syndrome: A working case definition." Annals of Internal Medicine 108:387-389, 1988. Jaret, Peter. "Chronic fatigue syndrome: An update." Glamour, Nov. 1992. Petersdorf, R. G.; Adams, R. D.; Braunwald, E.; et al. Harrison's Principles of Internal Medicine 10th Edition (New York: McGraw-Hill, 1983).
2. Jones, J. F.; Ray, G.; Minnich, L. L.; et al. "Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illness: Elevated anti-early antigen antibodies." Annals of Internal Medicine 102: I-7, 1985.
Strauch, B.; Andrews, L.; Miller, G.; et al. "Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppression drugs." Lancet i:234, 1974. Straus, S. E.; Tosato, F.; Armstrong, G.; et al. "Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection." Annals of Internal Medicine 102:7-16, 1985.
3. Dubois, R. E.; Seely, J. R.; Brus, I.; et al. "Chronic mononucleosis syndrome." South. Med. J. 77: 1376-1382, 1984 Jones, J. F. "Chronic Epstein-Barr virus infection in children." Pediatric Infectious Disease 5:503-504, 1986. Sixbey, J. W.; Nedrud, J. G.; Raab-Traub, N.; Hanes, R. A.; Pagano, J. S. "Epstein-Barr virus replication in oropharyngeal epithelial cells." New England Journal of Medicine 310: I 225-1230, 1984. Tobi, M.; Morag, A.; Ravid, Z.; et al. "Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection." Lancet i:61-64, 1982.
4. Andiman, W. A. "The Epstein-Barr virus infections in childhood." Journal of Pediatrics 95:171, 1979. Rapp, C. E., and J. F. Hewetson. "Infectious mononucleosis and the Epstein-Barr virus.'' American Journal of Disease Children 132:78, 1978.
5. Henle, W.; Henle, G.; Lennette, E. T. "The Epstein-Barr virus." Scientific American 241:48, 1979.
6. Miller, G.; Niederman, J. D.; Andrews, L. "Prolonged oropharyngeal excretion of EpsteinBarr virus after infectious mononucleosis." New England Journal of Medicine 288:229, 1973. Rocchi, G.; DeFelici, A.; Ragona, G.; et al. "Quantitative evaluation of Epstein-Barr virusinfected mononuclear peripheral blood leukocytes in infectious mononucleosis." New England Journal of Medicine 296:132, 1977.
7. Donovan, Patrick M. " Chronic mononucleosis-like syndrome: Primary EBY infection or indicator of immune system dysfunction?" In Pizzorno and Murray, Chronic Mononucleosis, Nov. 16, 1987, p. 1.
8. Henig, Robin Marantz. A Dancing Matrix: Voyages Along the Viral Frontier. (New York: Alfred A. Knopf, 1993), pp. 58-61.
9. Gallo, Robert. Virus Hunting: AIDS, Cancer, and the Human Retrovirus: A Story of Scientific Discovery. (New York: Basic Books, 1991 ), p. 96.
10. Winslow, Ron. "Virus may have role in causing chronic fatigue." The Wall Street Journal, September 16, 1991.
11. Cowley, Geoffrey and Mary Hager. "A clue to chronic fatigue." Newsweek, LifestyleMedicine Section, 1991.
12. Renis, H. E. " In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy 167-172, 1970.

BÖLÜM 8: HIV POZİTİF (+) KANIN HIV NEGATİFE (-) DÖNDÜRÜLMESİ

BÖLÜM 8 KAYNAKÇA:
1. Brink, W. D. "Reexamining AIDS/potential non-toxic protocols." Townsend Letter for Doctors & Patients, pp. 50-53, Dec. 1996.
2. Sherman, W. " Selling vials of hope." Longevity, March 1992, pp. 61-69
3. Arno, P. S., and Feiden, K.L. Against the Odds: The Story of AIDS Drug Development, Politics and Profit (New York: HarperCollins, 1992).
4. "Scientist reports that HIV in the presence of HHV-6A replicates 10 to 15 times faster." Positive Health News, Report No. I 0, Winter 1995, p. 11.
5. Duesberg, P.H. "AIDS epidemiology: Inconsistencies with human immunodeficiency virus and with infectious disease." Proceedings of the National Academy of Science 88: [575-1579, 1991.Duesberg, P.H. "Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation." Proceedings of the National Academy of Science 86:755-764, 1989.
6. The American Academy for the Advancement of Science conference, June 22, 1995, San Francisco State University.
7. Benjamini, E., and Leskowitz, S. Immunology: A Short Course (New York: John Wiley & Sons, Inc., 1991), p. 154.
8. Konlee, M. "Protease inhibitors-Back to 'Eden.'" Positive Health News 11:2, Spring 1996.
9. Ibid., p. 14.
10. Konlee, M. How to Reverse Immune Dysfunction (West Allis, WI: Keep Hope Alive, 1996).

BÖLÜM 9: BULAŞICI SOĞUK ALGINLIĞI VE GRİP İÇİN HIZLI TEDAVİ

BÖLÜM 9 KAYNAKÇA:
1. Beyerman, H. C.; van Dijck, L. A.; Levisalles, J.; Melera, A.; Veer, W.L.C. Bulletin of Science and Chemistry. France. 10:1812 1961
2. Sorel, op. cit. Hirschman, S. Z. Science 173:441 1971.
3. Hirschman, op. cit. Panizzi, L.; Scarpati, M. L.; Oriente, G. Gazz. Chim. Ital. 90:1449 1960.
4. Hirschman, S. Z. "Inactivation of DNA polymerases of murine leukaemia viruses by calcium elenolate." Nature New Biology 238:277-279 August 30, 1972. Renis, H. E. "Influenza virus infection of hamsters. A model for evaluating antiviral drugs." Antimicrobial Agents and Chemotherapy 167 (American Society for Microbiology 1969).
5. Mills, J. "What's new about the common cold? Results of surprising studies." Modem Medicine November 1981. Soret, M. G. "Antiviral activity of calcium elenolate on parainfluenza infection of hamsters." Antimicrobial Agents and Chemotherapy 160 (American Society for Microbiology 1969).
6. Renis, H. E. "Inactivation of myxoviruses by calcium elenolate." Antimicrobial Agents and Chemotherapy pp. I 94-199 August 1975. Renis, H. E. "In vitro antiviral activity of calcium elenolate." Antimicrobial Agents and Chemotherapy pp. 167-172 1969.
7. Stoffman, P. The Family Guide to Preventing & Treating 100 Infectious Illnesses. (New York: John Wiley & Sons Inc. 1995) p. 153.
8. Renis, H. E. "Influenza virus infection of hamsters. A model for evaluating antiviral drugs." Archives of Virology 54:85-93 1977.
9. Katz, B. Z. and Thomson, R. B. "Viral infections of the lower respiratory tract." In The Biologic and Clinical Basis of Infectious Diseases 5th edition. Editors S. T. Shulman J. P. Phair L. R. Peterson J. R. Warren (Philadelphia: W. B. Saunders Co. 1997) pp. 143-156.
10. Renis, op. cit. 1975.
11. Renis, op. cit. 1969.
12. Till, M. "Viral infections of the central nervous system." In The Biologic and Clinical Basis of Infectious Diseases 5th edition. Editors S. T. Shulman J.P. Phair L. R. Peterson J. R. Warren (Philadelphia: W. B. Saunders Co. I 997) pp. 327-343.
13. Stoffman op. cit., pp. 248-251.

BÖLÜM 10: ZEYTİN YAPRAĞI EKSTRAKTININ ANTİ BAKTERİYEL ÖZELLİKLERİ

BÖLÜM 10 KAYNAKÇA:
1. Mcarty, M. "The hemolytic streptococci." In Bacterial and Mycotic Infections of Man, 3rd edition, editor Rene J. Dubos (Philadelphia: J. B. Lippincott Company, 1958), p. 248.
2. Warren, J. R. "Bacteria-host interactions." In The Biologic and Clinical Basis of Infectious Diseases, 5th edition. Editors S. T. Shulman, J.P. Phair, L. R. Peterson, J. R. Warren (Philadelphia: W. B. Saunders Co., 1997), pp. 29-30.
3. Fleming, H.P., and Etchells, J. L. "Occurrence of inhibitor of lactic acid bacteria in green olives." Applied Microbiology 14:1178-1184, 1967. Vaughn, R.H. in Industrial Fermentations. Editors L.A. Underkotler, and R. J. Hickey, Vol. 2 (New York: Chemical Publishing, 1954).
4. Fleming, H.P.; Walter, W. M.; Etchells, J. L. Applied Microbiology 18:859-860, 1969. Rutz-Barba, J. L.; Rios-Sanchez, R. M.; Fedriant-Iriso, C.; Olias, J.M.; Rios, J. L.; Ji-Menez, Diaz, R . Syst. Applied Microbiology 13:199-205, 1990.
5. Vazqeuz-Roncero, A.; Maestro Duran, M.; Graciani, C. E. Grasas Aceites 25:341-345, 1974.
6. Moreno, E.; Perez, J.; Ramos-Cormezana, A.; Martinez, J. Microbios 51:169-174, 1987.
7. Paredes, M. J.; Monteleolina-Sanchez, M.; Moreno, E.; Perez, J.; Ramos-Cormenzana, A.; Martinez, J. Chemosphere 15:659-664, 1986. Paredes, M. J.;M oreno, E.;R amos-Cormenzana, A.; Martinez, J. Chemosphere 16: 1557-1564, 1987.
8. Rodriguez, M. M.; Perez, J.; Romps-Cormenzana, A.; Martinez, J. Journal of Applied Bacteriology 64:219-225
9. Inven, B., and Henis, Y. Journal of Applied Bacteriology 33:721-732, 1970 Paster, N.; Juven, B. J.; Harshemesh, H. Journal of Applied Bacteriology 64:293-297, 1988.
10. Nychas, G. J.E.; Tassou, S. C.; Board, R. G. Letters in Applied Microbiology 10:217-220, 1990.
11. Elliott, G. A.; Buthala, D. A.; De Young, E. N. ''Preliminary safety studies with calcium elenolate, an antiviral agent." Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 1970.
12. Walker, M. "Dr. William Donald Kelley charges contamination of pancreatic enzymes." Townsend Letter for Doctors 65:535-551, Dec. 1988.
13. Mortimer, P. R., and McCann, G. ''Food poisoning episodes associated with Bacillus cereus in fried rice.'' Lance/ I: 1043-1045, 1974.
14. Walker, op. cit., pp. 547-548.
15. Tassou, C. C.; Nychas, G. J.E.; Board, R. G. "Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores." Biotechnology Applied Biochemistry 13:231-237, 1991.
16. Parker, M. S. and Bradley, M.J. Canadian Journal of Microbiology 141 :745-746, 1968.
17. Sierra, G. Canadian Journal of Microbiology 16:51-52, 1970.
18. Bourquelot, E., and Vintilesco, J. Canadian Royal Academy of Sciences 147:533-535, 1908. Creuss, W. V., and Alsberg, C. L. Journal of the American Chemical Society 56:2115-2117, 1934. Fleming, H. P., et al. Applied Microbiology 6(5):773-782, 1973. Kubo, I., et al. Journal of Chemical Ecology 11(2):251-263, 1985. Panizzi, L., et al. Gazz. Chim. Ital. 90: 1449-1485, 1960. Petkov, V., and Manolov, P. Drug Research 22(9): 1476-1486, 1972.
19. Gariboldi, P., et al. Phytochemistry 25(4):865-869, 1986. Kelley, R. C., et al. Journal of the American Chemical Society 95(21):7155-7156, 1973. Veer, W. L. C. U.S. Patent 3,033,877, 1962. Veer, W. L. C., et al. J. Rec. Trav. Chim. Pay Bas. 76:839-840, 1957.
20. Fleming, op. cit., pp. 777-782. Hirschman, S. Z. Nature (New Biology) 238:227-229, 1972. Renis, H. E. Antimicrobial Agents & Chemotherapy 1970, pp. 167-172.
21. Elliot, G. A., et al. Antimicrobial Agents & Chemotherapy, 1970, pp. 173-176. Sorel, M.G. Antimicrobial Agents & Chemotherapy, 1970, pp. 160-166.
22. Creuss, W. V. IV Congress International Tech. Chim. Ind. Agr., Brussels. 3:638-645, 1935. Creuss and Alsberg, op. cit.
23. Gariboldi, P., op. cit. Pizzalato, G., et al. Tetrahedron 44(11):3203-3208, 1988

BÖLÜM 11: MAYA SENDROMU VE DİĞER MANTAR HASTALIKLARININ TEDAVİSİ

BÖLÜM 11 KAYNAKÇA:
1. Moss, E. S., and McQuown. Atlas of Medical Mycology (Baltimore: Williams & Wilkins Co., 1960).
2. Emond, R. T. D.; Rowland, H. A.; Welsby, P. D. Color Atlas of Infectious Diseases, 3rd edition (London: Mosby-Wolfe, 1995). Hazen, E. L., and Reed, F. C. Laboratory Identification of Pathogenic Fungi Simplified (Springfield, IL: Charles C Thomas, 1960). Jacobson, H. P. Fungous Diseases: A Clinico-Mycological Text (Springfield, IL: Charles C Thomas, 1932). Moss & McQuown, op. cit., pp. 8-9.
3. Trowbridge, J.P., and Walker, M. The Yeast Syndrome: How to Help Your Doctor Identify and Treat the Real Cause of Your Yeast-Related Illness (New York: Bantam Books, 1986), pp. 72-77.
4. Trowbridge, J.P., and Walker, M. Yeast-Related Illnesses (Byram, NY: Devin-Adair, 1985).
5. Trowbridge & Walker, op cit.
6. Yutsis, P., and Walker, M. The Downhill Syndrome: lf Nothing's Wrong, Why Do I Feel So Bad? How to Overcome Generalized Tiredness, Disabling Fatigue or Outright Exhaustion and Restore High-Level Wellness to Your Body & Mind. (Garden City Park, NY: Avery Publishing Group, Inc., 1997), pp. 83-84.

BÖLÜM 12: VÜCUDUMUZDA YAŞAYAN PARAZİTLERDEN NASIL KURTULURUZ

BÖLÜM 12 KAYNAKÇA:
1. Yutsis, P. I., and Walker, M. The Downhill Syndrome (Garden City Park, NY: Avery Publishing Group, Inc., 1997).
2. Gittleman, A. L. Guess What Came to Dinner: Parasites and Your Health (Garden City Park, NY: Avery Publishing Group, Inc., 1993).
3. Kristoff, N. D. "Malaria makes a comeback, and is more deadly than ever.'' The New York Times, Vol. CXLLVI, No. 50,666, January 8, 1997, p. A 1.

BÖLÜM 13: ZEYTİN YAPRAĞI EKSTRAKTININ BAŞARILI KULLANIMI İÇİN SONUÇ NİTELİĞİNDE BİLGİLER

BÖLÜM 13 KAYNAKÇA:
1. U. S. Congress, General Accounting Office, Automated Medical Records: Leadership Needed to Expedite Standards Development (Washington, DC: General Accounting Office, 1993).
2. Kubo, I., et al. "A multichemical defense mechanism of bitter olive Olea europaea (Oleaceae)-ls oleuropein a phytoalexin precursor?" Journal of Chemistry & Ecology 11 (2):25 J-263, 1985.
3. Heinze, J. E., et al. ''Specificity of the antiviral agent calcium elenolate." Antimicrobial Agents in Chemotherapy 8(4):421-425, 1975. Juven, B., et al. "Studies on the mechanism of the antimicrobial action of oleuropein." Journal of Applied Bacteriology 35:559-567, 1972.
4. Panizzi, L., et al. "The constitution of oleuropein, a bitter glucoside of the olive with hypotensive action." Gazz. Chim. Ital. 1449-1485, 1960. Samuelsson, G. "The blood pressure lowering factor in leaves of Olea europaea." Farmacevtisk Revy 15:229-239.
5. Visoli, F., and Galli, C. " Oleuropein protects low density lipoprotein from oxidation." Life Sciences 55(24): 1965-1971, 1994.
6. "Researchers find how disease-resistant plants recognize bacteria." Press release, Purdue News, December 20, 1996.
7. Fredrickson, W.R. "A study of the efficacy of the olive preparation Tinctura Olea foliorumin treatment of herpetic infection." Townsend Letter for Doctors & Patients 166:110-111, May 1997.
8. Stephenson, J. ''Investigators seeking new ways to stem rising tide of resistant fungi." Journal of the American Medical Association 277(1):5-6, Jan. 1, 1997.